On 28 July, Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $3.15, $0.44 better than the analyst estimate of $2.71. Revenue for the quarter came in at $8.24 billion versus the consensus estimate of $7.61 billion. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 51.50% and weekly performance is -2.21%. On last trading day company shares ended up $115.30. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is -1.04%.
ON 28 July, Pfizer Inc. (NYSE:PFE) Reported revenues decreased $920 million, or 7%, which reflects operational growth of $125 million, or 1%, more than offset by the unfavorable impact of foreign exchange of $1.0 billion, or 8%. Excluding the impact of foreign exchange, adjusted diluted EPS increased by approximately 6%.Pfizer Inc. (NYSE:PFE) shares decreased -1.81% in last trading session and ended the day at $35.17. PFE Gross Margin is 81.30% and its return on assets is 5.30%. Pfizer Inc. (NYSE:PFE) quarterly performance is 5.55%.
Baxter International Inc. (NYSE:BAX) declared a regular quarterly dividend of $0.115 per Baxter common share. This cash dividend is payable on October 1, 2015 to shareholders of record as of September 4, 2015.On 06 August, Baxter International Inc. (NYSE:BAX) shares decreased -0.47% and was closed at $41.93. BAX EPS growth in last 5 year was -0.20%. Baxter International Inc. (NYSE:BAX) year to date (YTD) performance is 6.97%.
Opko Health, Inc. (NYSE:OPK) reported Net loss for the three and six months ended June 30, 2015 was $42.8 million and $159.9 million and included increased operating expenses including increased research and development expense of $13.3 million and $17.8 million, respectively, in comparison to the 2014 periods. Opko Health, Inc. (NYSE:OPK) ended the last trading day at $13.90. Company weekly volatility is calculated as 5.03% and price to cash ratio as 18.49. Opko Health, Inc. (NYSE:OPK) showed a weekly performance of -15.14%.
Mylan N.V. (NASDAQ:MYL) said it will hold its extraordinary general meeting of shareholders in connection with its proposed acquisition of Perrigo Co plc (TASE) at the Okura Hotel Amsterdam on Friday, August 28, 2015. Mylan N.V. (NASDAQ:MYL) shares increased 1.47% in last trading session and ended the day at $55.40. MYL Gross Margin is 46.50% and its return on assets is 5.10%. Mylan N.V. (NASDAQ:MYL) quarterly performance is -21.30%.